Disease activity in graves' ophthalmopathy: Diagnosis with orbital MR imaging and correlation with clinical score

Neuroradiology Journal

Volumn 26, Issue 5, 2013, Pages 555-564

  Tortora, Fabio ^a   Cirillo, Mario ^a   Ferrara, Marco ^a   Belfiore, Maria Paola ^a   Carella, Carlo ^a   Caranci, Ferdinando ^b   Cirillo, Sossio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Basedow Graves' disease; CAS; Proptosis; Thyroid

Indexed keywords

GADOBUTROL; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; DISEASE ACTIVITY; ENDOCRINE OPHTHALMOPATHY; EYE PAIN; EYELID ERYTHEMA; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; THYROID DISEASE; TREATMENT OUTCOME;

EID: 84888814173     PISSN: 19714009     EISSN: None     Source Type: Journal    
DOI: 10.1177/197140091302600509     Document Type: Article

References (31)

1. Mourits MP, Prummel MF, Wiersinga WM, et al. Clinical activity score as a guide in the management of patients with Graves' Ophthalmopathy. Clin Endocrinol. 1997; 47 (1): 9-14. (Pubitemid 27313981)
2. Mourits MP, Koornneef L, Wiersinga WM, et al. Clinical criteria for the assessment of disease activity in Graves' Ophthalmopathy: a novel approach. Br J Ophthalmol. 1989; 73 (8): 639-644. (Pubitemid 19202075)
3. Bartalena L, Baldeschi L, Dickinson AJ, et al. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid. 2008; 18 (3): 333-346. (Pubitemid 351415802)
4. Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008; 158 (3): 273-285. (Pubitemid 351404990)
5. Prummel MF, Gerding MN, Zonneveld FW, et al. The usefulness of quantitative orbital magnetic resonance imaging in Graves' Ophthalmopathy. Clin Endocrinol. 2001; 54 (2): 205-209. (Pubitemid 32193522)
6. Dickinson AJ, Perros P. Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of detailed protocol with comparative photographs for objective assessment. Clin Endocrinol. 2001; 55 (3): 224-225.
7. Tachibana S, Murakami T, Noguchi H, et al. Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' Ophthalmopathy. Endocr J. 2010; 57 (10): 853-861.
8. Stiebel-Kalish H, Robenshtok E, Hasanreisoglu M, et al. Treatment modalities for Graves' ophthalmopathy: systematic review and meta-analysis. Clin Endocrinol Metab. 2009; 94 (8): 2708-2716.
9. Bahn RS. Graves' ophthalmopathy. N Engl J Med. 2010; 362 (8): 726-738.
10. Hoang JK, et al. What's in a name? Eponyms in head and neck imaging. Clin Radiol. 2010; 65 (3): 237-245.
11. Kirsch EC, Kaim AH, De Oliveira MG, et al. Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy - A pilot study at 1.5 T. Neuroradiology. 2010; 52 (2): 91-97.
12. Cakirer S, Cakirer D, Basak M, et al. Evaluation of extraocular muscles in the edematous phase of Graves Ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging. J Comput Assist Tomogr. 2004; 28 (1): 80-86. (Pubitemid 38057859)
13. Kirsch E, Hammer B, von Arx G. Graves' orbitopathy: current imaging procedures. Swiss Med Wkly. 2009; 139 (43-44): 618-623.
14. Kahaly GJ. Imaging in thyroid-associated orbitopathy. Eur J Endocrinol. 2001; 145: 107-118. (Pubitemid 32707596)
15. Ott M, Breiter N, Albrecht CF, et al. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy? Br J Radiol. 2002; 75 (894): 514-517. (Pubitemid 34863407)
16. Breiman L. "Random forests". Mach Learn. 2001; 45 (1): 5-32. (Pubitemid 32933532)
17. Strianese D, Piscopo R, Elefante A, et al. Unilateral proptosis in thyroid eye disease with subsequent contralateral involvement: retrospective follow-up study. BMC Ophthalmol. 2013; 13: 21.
18. Elisabeth R, DeLong DM, DeLong Dl L, et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44 (3): 837-845.
19. Dickinson AJ, Perros P. Thyroid-associated orbitopathy: who and how to treat. Endocrinol Metab Clin N Am. 2009; 38 (2): 373-388.
20. Caranci F, Cicala D, Cappabianca S, et al. Orbital fractures: role of imaging. Semin Ultrasound CT MRI. 2012; 33 (5): 385-439.
21. European Group on Graves' Orbitopathy (EUGOGO), Wiersinga WM, Perros P, et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol. 2006; 155 (3): 387-389.
22. Ceccarelli C, Bencivelli W, Vitti P, et al. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study. Clinical Endocrinology. 2005; 62 (3): 331-335. (Pubitemid 40380414)
23. Nagy EV, Toth J, Kaldi I, et al. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia. Eur J Endocrinol. 2000: 142 (6): 591-597. (Pubitemid 30399489)
24. Mayer EJ, Fox DL, Herdman G, et al. Signal intensity, clinical activity and cross sectional areas on MRI scans in thyroid eye disease. Eur J Radiol. 2005; 56 (1): 20-24. (Pubitemid 41316481)
25. Utech CI, Khatibnia U, Winter PF, et al. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy. Thyroid. 1995; 5 (3): 185-193.
26. Lennerstrand G, Tian S, Isberg B, et al. Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease. Acta Ophthalmol Scand. 2007; 85 (2): 192-201.
27. Yokoyama N, Nagataki S, Uetani M, et al. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. Thyroid. 2002: 12 (3): 223-227. (Pubitemid 34259803)
28. Elefante A, Caranci F, Del Basso De Caro ML, et al. Paravertebral high cervical chordoma. A case report. Neuroradiol J. 2013; 26 (2): 227-232.
29. Mourits MP. Diagnosis and differential diagnosis of Graves' orbitopathy. In: Wiersinga WM, Kahaly GJ eds. Graves' orbitopathy: a multidisciplinary approach. Basel: Karger; 2007. p. 66-77.
30. Amano Y, Amano M, Kumazaki T. Normal contrast enhancement of extraocular muscles: fat-suppressed MR findings. Am J Neuroradiol. 1997; 18 (1): 161-164. (Pubitemid 27036645)
31. Taoka T, Iwasaki S, Uchida H, et al. Enhancement pattern of normal extraocular muscles in dynamic contrast-enhanced MR imaging with fat suppression. Acta Radiol. 2000; 41 (3): 211-216.